ADHD and Substance Use: Risk, Self-Medication, and the Path Out

The link between ADHD and substance use disorder is one of the most consistent findings in adult ADHD research. People with ADHD have elevated rates of alcohol, cannabis and stimulant use, both in problematic and non-problematic patterns, and the relationship between the two is shaped by self-medication, impulsivity and the long-term consequences of untreated ADHD. This article covers what the evidence shows, how the two conditions interact, and what UK treatment looks like when both are present.

What the evidence shows

The 2011 Lee et al. meta-analytic review in Clinical Psychology Review pooled prospective data from multiple longitudinal studies and is one of the most-cited sources ^[2]. The headline findings:

• Childhood ADHD predicts substance use disorder in adulthood, with around twice the odds compared with children without ADHD
• The risk is elevated for nicotine, alcohol, cannabis and illicit drug use disorders
• Co-occurring conduct disorder substantially amplifies the risk; ADHD without conduct disorder carries a more modest elevation
• The risk applies to both men and women with ADHD

The 2012 van Emmerik-van Oortmerssen et al. meta-analysis looked at the prevalence of ADHD in substance use disorder patients and found that around 23 percent of adults seeking treatment for substance use also meet criteria for ADHD, with the figure higher for stimulant use disorder specifically ^[4].

The 2014 Chang et al. study, which used Swedish national registry data with over 38,000 patients, found that periods of being on ADHD medication were associated with a lower risk of substance use disorder events compared with periods off medication, in the same individuals ^[5]. The data did not support the longstanding clinical concern that stimulant treatment increases substance use risk; it pointed the other way.

Why the two travel together

Several mechanisms contribute, and most patients with both will have more than one in play ^{[3, 4]}:

Self-medication

The most commonly described mechanism. People with undiagnosed or unmanaged ADHD find that certain substances temporarily reduce their ADHD difficulties. Cannabis often quiets the mental racing and helps with sleep. Alcohol can quieten anxiety and the cognitive over-activity that comes with the day's accumulated load. Caffeine and nicotine improve focus. Cocaine and methamphetamine, in the most worrying version of the pattern, can produce a paradoxical calming effect via the same dopamine and noradrenaline mechanisms as prescription stimulants.

The self-medication pattern is recognisable in adult ADHD assessment. People describe specific reasons for using specific substances at specific times, often with surprising clinical accuracy about which neurotransmitter system they are targeting (without using that language).

Impulsivity

The same impulsivity that drives other ADHD difficulties drives the initiation and continuation of substance use. The "one more drink" decision, the "I will start cutting down tomorrow" pattern, and the difficulty with delayed reward are all amplified by the underlying impulsivity.

Reward and dopamine signalling

Both ADHD and substance use disorder involve disrupted reward and dopamine signalling. Substances of misuse produce stronger reward responses in brains with reduced baseline dopamine signalling, which makes the cycle harder to interrupt.

Co-occurring mental health

Anxiety, depression and trauma-related difficulties are all over-represented in ADHD and all drive substance use independently. The combination of ADHD with one or more of these conditions is part of why substance use risk is elevated.

Environmental and social factors

Adults with unmanaged ADHD often spend more time in environments where substance use is normalised: certain night-time work patterns, late-night social settings, social groups built around drinking culture. These environmental factors compound the biological vulnerability.

How alcohol specifically interacts with ADHD

Alcohol is the most common substance involved in problematic use in adults with ADHD in the UK ^[3]. The relationship has specific features:

• Adults with ADHD report higher rates of alcohol use disorder than baseline
• Many describe using alcohol to quieten the cognitive over-activity at the end of the day
• Alcohol substantially worsens ADHD symptoms the day after consumption (impaired focus, irritability, increased emotional dysregulation)
• Heavy drinking interacts with the cardiovascular effects of stimulant medication
• Recovery from alcohol use disorder in adults with ADHD is more sustainable when the ADHD is also treated

Alcohol and ADHD: friends, foes or just a fling covers the daily-life detail more directly.

How stimulant treatment fits

A common patient and clinician concern is whether ADHD stimulants increase substance use risk. The Chang et al. 2014 study and several subsequent cohort studies point the other way: stimulant treatment in adults with ADHD is associated with reduced substance use risk, particularly when the medication is used as prescribed ^[5]. The mechanism is plausible: stimulant treatment reduces the underlying ADHD difficulties that drive self-medication, and the reduction in impulsivity reduces the initiation of substance use.

This does not mean stimulants are appropriate for every adult with ADHD and a substance use history. The clinical conversation considers:

• The current substance use picture (active, in recovery, brief lapse, long-standing pattern)
• The substance involved (cocaine and methamphetamine use carry specific concerns about the interaction with prescription stimulants)
• The recovery trajectory and the support around it
• Patient preference

For some adults with ADHD and a history of stimulant misuse, atomoxetine or guanfacine (both non-controlled drugs) is the preferable starting point. For others, monitored stimulant treatment under specialist supervision is the right approach. NICE NG87 acknowledges co-occurring substance use disorder and supports careful prescribing decisions in this group ^[1].

How treatment is sequenced

The practical principles when ADHD and substance use disorder are both present ^{[1, 3]}:

Acute substance use is treated as the medical priority

Active alcohol or drug dependence with medical complications takes clinical priority. ADHD assessment and treatment usually follow detoxification and stabilisation.

Substance use treatment should be ADHD-aware

Standard substance use disorder treatment (motivational interviewing, structured psychological therapies, peer support such as AA, NA, SMART Recovery) can be delivered in an ADHD-aware way that recognises the structural difficulties patients with ADHD have with engagement, follow-through and sustained behavioural change.

ADHD treatment can substantially support recovery

Treating the ADHD reduces a major driver of the underlying pattern. Recovery rates are higher in adults with co-occurring ADHD when the ADHD is treated alongside the substance use disorder.

Honest disclosure matters

Patient honesty about substance use with the prescriber is essential. Stimulant prescriptions are controlled drugs and the prescribing decision depends on accurate information. Hiding substance use can produce dangerous drug interactions and inappropriate prescribing.

Whole-picture support

ADHD diagnosis is more than medication particularly applies here. Recovery from substance use disorder requires psychological, social and structural change as well as pharmacological treatment.

What this means in practice

• Childhood ADHD roughly doubles the risk of adult substance use disorder. Around 23 percent of adults in substance use treatment also meet criteria for ADHD.
• Self-medication is the most commonly described mechanism. People with unmanaged ADHD find that certain substances temporarily reduce their ADHD difficulties.
• Stimulant ADHD treatment in adults is associated with reduced substance use risk, not increased risk, when used as prescribed.
• Treatment usually addresses both conditions. Severe active substance use is the medical priority; ADHD treatment follows stabilisation.
• Atomoxetine or guanfacine (non-controlled drugs) are sometimes preferable starting points where a history of stimulant misuse is in the picture.

When to speak to a professional

Speak to your GP about both substance use and possible ADHD. NHS routes for substance use treatment (community drug and alcohol services) and for ADHD assessment exist; Right to Choose in England applies to ADHD. NeuroFX offers private ADHD assessment for adults with co-occurring substance use considered honestly throughout. National support includes Alcoholics Anonymous, Narcotics Anonymous, SMART Recovery, FRANK (talktofrank.com or 0300 123 6600), and the NHS Substance Misuse Helpline. Seek urgent help via 111, 999 or A&E for any acute mental health crisis or substance-related medical emergency.

Sources

1. NICE. Attention deficit hyperactivity disorder: diagnosis and management. NG87. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng87
2. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clinical Psychology Review. 2011;31(3):328-341.
3. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews. 2021;128:789-818.
4. van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug and Alcohol Dependence. 2012;122(1-2):11-19.
5. Chang Z, Lichtenstein P, Halldner L, et al. Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry. 2014;55(8):878-885.